secwatch.observer — SEC 8-K summary
======================================

Issuer:     Acer Therapeutics Inc. (—)
CIK:        0001069308
Form:       8-K
Filed at:   2023-11-02T23:59:59+00:00
Accession:  0001193125-23-268923
Event type: other_material
Sentiment:  negative
Materiality: 0.90
Item codes: 1.01, 3.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Acer receives Nasdaq delisting notice; trading suspended Nov 9; merger vote critical for survival
--------------------------------------------------------------------------------

- Nasdaq will suspend ACER trading at open on Nov 9, 2023; company will not appeal, leading to OTC Pink listing.
- Bridge loan from Zevra increased from $16.5M to $18M via First Amendment dated Oct 31, 2023.
- ISS and Glass Lewis recommend shareholders vote 'FOR' merger with Zevra at Nov 8 special meeting.
- If merger not approved, ACER will trade OTC Pink starting Nov 9 and may be forced to cease operations.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1069308/000119312523268923/0001193125-23-268923-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1069308/000119312523268923/d684425d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-268923

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer